Emilia M. Thiesson

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Feasibility of conducting brand-specific influenza vaccine effectiveness studies in three Nordic countries, Denmark, Finland, Sweden.

Feasibility of conducting brand-specific influenza vaccine effectiveness studies in three Nordic countries, Denmark, Finland, Sweden.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 27, 2026

Safety of JN.1-Updated mRNA COVID-19 Vaccines.

Safety of JN.1-Updated mRNA COVID-19 Vaccines.

Journal: JAMA network open

Published: July 28, 2025

Brand-specific influenza vaccine effectiveness in three Nordic countries during the 2024-2025 season: a target trial emulation study based on registry data.

Brand-specific influenza vaccine effectiveness in three Nordic countries during the 2024-2025 season: a target trial emulation study based on registry data.

Journal: The Lancet regional health. Europe

Published: July 18, 2025

Comparative effectiveness of monovalent XBB.1.5 containing covid-19 mRNA vaccines in Denmark, Finland, and Sweden: target trial emulation based on registry data.

Comparative effectiveness of monovalent XBB.1.5 containing covid-19 mRNA vaccines in Denmark, Finland, and Sweden: target trial emulation based on registry data.

Journal: BMJ medicine

Published: September 02, 2024

Comparative effectiveness of bivalent BA.4-5 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: A nationwide cohort study.

Comparative effectiveness of bivalent BA.4-5 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: A nationwide cohort study.

Journal: The Journal of infection

Published: June 20, 2024

Inflammatory Risk Factors for Chronic Subdural Hematoma in a Nationwide Cohort.

Inflammatory Risk Factors for Chronic Subdural Hematoma in a Nationwide Cohort.

Journal: Journal of inflammation research

Published: June 12, 2024

Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.

Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.

Journal: JAMA

Published: February 26, 2024

COVID-19 Vaccine Effectiveness Among Adolescents.

COVID-19 Vaccine Effectiveness Among Adolescents.

Journal: Pediatrics

Published: October 05, 2023

Safety of BA.4-5 or BA.1 bivalent mRNA booster vaccines: nationwide cohort study.

Safety of BA.4-5 or BA.1 bivalent mRNA booster vaccines: nationwide cohort study.

Journal: BMJ (Clinical research ed.)

Published: July 25, 2023

Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study.

Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study.

Journal: BMJ (Clinical research ed.)

Published: July 25, 2023

Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.

Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.

Journal: BMJ (Clinical research ed.)

Published: July 24, 2023

Association between atopic disease and vaccination granulomas: A nested case-control study.

Association between atopic disease and vaccination granulomas: A nested case-control study.

Journal: Contact dermatitis

Published: July 07, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026